These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14746921)

  • 1. Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice.
    Paris D; Quadros A; Humphrey J; Patel N; Crescentini R; Crawford F; Mullan M
    Brain Res; 2004 Feb; 999(1):53-61. PubMed ID: 14746921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.
    Paris D; Humphrey J; Quadros A; Patel N; Crescentini R; Crawford F; Mullan M
    Neurol Res; 2003 Sep; 25(6):642-51. PubMed ID: 14503019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.
    Paris D; Bachmeier C; Patel N; Quadros A; Volmar CH; Laporte V; Ganey J; Beaulieu-Abdelahad D; Ait-Ghezala G; Crawford F; Mullan MJ
    Mol Med; 2011; 17(3-4):149-62. PubMed ID: 21170472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature.
    Townsend KP; Obregon D; Quadros A; Patel N; Volmar Ch; Paris D; Mullan M
    Ann N Y Acad Sci; 2002 Nov; 977():65-76. PubMed ID: 12480734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nilvadipine (a dihydropyridine-type calcium entry blocker) on cerebral blood flow in acute experimental brain ischemia in rats.
    Tanaka R; Miyasaka Y; Maruyama S; Nagai S; Fujii K
    Neurol Res; 1996 Aug; 18(4):325-8. PubMed ID: 8875450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.
    Paris D; Ait-Ghezala G; Bachmeier C; Laco G; Beaulieu-Abdelahad D; Lin Y; Jin C; Crawford F; Mullan M
    J Biol Chem; 2014 Dec; 289(49):33927-44. PubMed ID: 25331948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease.
    de Jong DLK; de Heus RAA; Rijpma A; Donders R; Olde Rikkert MGM; Günther M; Lawlor BA; van Osch MJP; Claassen JAHR
    Hypertension; 2019 Aug; 74(2):413-420. PubMed ID: 31203725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nilvadipine, a dihydropyridine type calcium channel blocker, on local cerebral blood flow in rats.
    Furuichi Y; Takakura S; Satoh H; Mori J; Kohsaka M
    Jpn J Pharmacol; 1992 Apr; 58(4):457-60. PubMed ID: 1405041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.
    Shin HK; Jones PB; Garcia-Alloza M; Borrelli L; Greenberg SM; Bacskai BJ; Frosch MP; Hyman BT; Moskowitz MA; Ayata C
    Brain; 2007 Sep; 130(Pt 9):2310-9. PubMed ID: 17638859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
    Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
    PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats.
    Takakura S; Satoh Y; Satoh H; Mori J; Kohsaka M
    Arch Int Pharmacodyn Ther; 1992; 319():38-48. PubMed ID: 1285672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nilvadipine on neuronal function in the ischemic cat brain.
    Takakura S; Furuichi Y; Satoh H; Mori J; Kohsaka M
    Surg Neurol; 1992 Apr; 37(4):255-60. PubMed ID: 1595035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis.
    Paris D; Patel N; DelleDonne A; Quadros A; Smeed R; Mullan M
    Neurosci Lett; 2004 Aug; 366(1):80-5. PubMed ID: 15265595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Shiino A; Matsuda M; Susumu T; Handa J
    Surg Neurol; 1991 Feb; 35(2):105-10. PubMed ID: 1990476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nilvadipine prevents the impairment of spatial memory induced by cerebral ischemia combined with beta-amyloid in rats.
    Iwasaki K; Egashira N; Takagaki Y; Yoshimitsu Y; Hatip-Al-Khatib I; Mishima K; Fujiwara M
    Biol Pharm Bull; 2007 Apr; 30(4):698-701. PubMed ID: 17409505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow changes after brain injury in human amyloid-beta knock-in mice.
    Abrahamson EE; Foley LM; Dekosky ST; Hitchens TK; Ho C; Kochanek PM; Ikonomovic MD
    J Cereb Blood Flow Metab; 2013 Jun; 33(6):826-33. PubMed ID: 23443172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.
    Taheri S; Yu J; Zhu H; Kindy MS
    J Alzheimers Dis; 2016 Oct; 54(3):1061-1072. PubMed ID: 27567835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single oral administration of nilvadipine on cerebral blood flow in chronic cerebral infarction.
    Kobayashi S; Yamaguchi S; Okada K; Suyama N; Bokura K; Murao M; Tsunematsu T
    Angiology; 1992 Oct; 43(10):801-9. PubMed ID: 1476267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.